ResMed| (RMD)CEO sold ~$1.13M

~$1.13M

Approx. value · 4,991 sh @ $226.33

480K

Holds after · shares reported

Traded

Oct 7, 2026

Filed

Oct 8, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Aug 7, 2026InsiderCEO sold ~$1.03M of RMD shares in the open market
2. Aug 13, 2026Company filing · Form 8-K · Auditor change, Executive changeChanged its auditor, and changed a top executive or board member (and 1 more item)“On August 13, 2026, Ronald Taylor, a director of Resmed, informed the Board that he will not stand for election at Resmed’s 2026 annual meeting of stockholders (the “Annual Meeting”) and intends to retire from the Board, effective at the Annual Meeting, which is expected to be held on November 18, 2026.”
3. Aug 27, 2026FDAFDA device clearance: EasyCare Tx 2
4. Sep 2, 2026InsiderDirector sold ~$228K of RMD shares in the open market
5. Sep 8, 2026InsiderCEO sold ~$1.11M of RMD shares in the open market
6. Oct 7, 2026 · this disclosureInsiderCEO sold ~$1.13M of RMD shares in the open market

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for ResMed|

For ResMed|, OQRO holds 8 insider filings (SEC Form 4 or Form 144), 1 Congress trade report and 19 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its RMD page.

Other recent filings by Michael J. Farrell, Chairman and CEO

• SEC Form 4 at ResMed| (RMD)Sep 10, 2026
• SEC Form 4 at ResMed| (RMD)Aug 11, 2026
• SEC Form 4 at ResMed| (RMD)Jul 9, 2026
• SEC Form 4 at ResMed| (RMD)Jun 9, 2026
• SEC Form 4 at ResMed| (RMD)May 11, 2026

The full history of Michael J. Farrell, Chairman and CEO is on the profile page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at ResMed|

• SEC Form 144Oct 7, 2026
• SEC Form 4Sep 10, 2026
• SEC Form 144Sep 8, 2026
• SEC Form 4Sep 4, 2026
• SEC Form 144Sep 2, 2026
• SEC Form 13F-HRAug 14, 2026

Everything OQRO holds on this company is on its RMD page.